Cargando…

Editorial: Identification and characterization of molecular targets in hepatocellular carcinoma

Detalles Bibliográficos
Autores principales:	Kumar, Vinay, Shukla, Surendra Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331817/ https://www.ncbi.nlm.nih.gov/pubmed/37435190 http://dx.doi.org/10.3389/fmolb.2023.1202614

Ejemplares similares

Editorial: Interventional therapy of hepatocellular carcinoma
por: Ji, Jiansong, et al.
Publicado: (2022)

Editorial: Molecular targeting of the tumor microenvironment for therapeutics in cancer metastasis
por: Dasari, Subramanyam, et al.
Publicado: (2023)

Identification of Two Molecular Subtypes of Hepatocellular Carcinoma Based on Dysregulated Immune LncRNAs
por: Lin, Hongsheng, et al.
Publicado: (2021)

Identification of an Immune-Related Prognostic Predictor in Hepatocellular Carcinoma
por: Wu, Lei, et al.
Publicado: (2020)

Editorial: Application of Systems Biology in Molecular Characterization and Diagnosis of Cancer
por: Zhang, Cheng, et al.
Publicado: (2021)

Molecular Associations and Clinical Significance of RAPs in Hepatocellular Carcinoma
por: Kumari, Sarita, et al.
Publicado: (2021)

Perspectives and mechanisms for targeting ferroptosis in the treatment of hepatocellular carcinoma
por: Li, Lanqing, et al.
Publicado: (2022)

Editorial: Characterizing the Multi-Faceted Dynamics of Tumor Cell Plasticity
por: Tripathi, Satyendra Chandra, et al.
Publicado: (2021)

Editorial: Molecular Targeted Therapy in Oncology: Lessons From Pharmacogenetics and Pharmacoepigenetics
por: Imani, Saber, et al.
Publicado: (2022)

Editorial: Application of systems biology in molecular characterization and diagnosis of cancer, Volume II
por: Wei, Yongjun, et al.
Publicado: (2022)

Editorial: Advances in the therapeutic targeting of human matrix metalloproteinases in health and disease
por: Bharadwaj, Shiv, et al.
Publicado: (2023)

Editorial: Cognitive Impairment and Peripheral Neuropathy From Chemotherapy: Molecular Mechanisms and Therapeutic Approaches
por: Milutinovic, Bojana, et al.
Publicado: (2022)

Identification of Arp2/3 Complex Subunits as Prognostic Biomarkers for Hepatocellular Carcinoma
por: Huang, Shenglan, et al.
Publicado: (2021)

Identification of a Pyroptosis-Related Prognostic Signature Combined With Experiments in Hepatocellular Carcinoma
por: Li, Huihui, et al.
Publicado: (2022)

Identification of the hub and prognostic genes in liver hepatocellular carcinoma via bioinformatics analysis
por: Gao, Qiannan, et al.
Publicado: (2022)

Editorial: Gynecological and gastrointestinal cancers: Recent advances in molecular diagnosis and targeted therapy
por: Zhang, Lan, et al.
Publicado: (2023)

Characterization of cellular senescence patterns predicts the prognosis and therapeutic response of hepatocellular carcinoma
por: Tang, Yuqin, et al.
Publicado: (2022)

Computational Identification of Immune- and Ferroptosis-Related LncRNA Signature for Prognosis of Hepatocellular Carcinoma
por: Huang, Anmin, et al.
Publicado: (2021)

Identification and Validation of the N6-Methyladenosine RNA Methylation Regulator YTHDF1 as a Novel Prognostic Marker and Potential Target for Hepatocellular Carcinoma
por: Bian, Saiyan, et al.
Publicado: (2020)

Editorial: Molecular Aspects of Mucopolysaccharidoses
por: Węgrzyn, Grzegorz, et al.
Publicado: (2022)

Ferroptosis Regulator Modification Patterns and Tumor Microenvironment Immune Infiltration Characterization in Hepatocellular Carcinoma
por: Liu, Dong-Li, et al.
Publicado: (2022)

Identification of Tumor Mutation Burden and Immune Infiltrates in Hepatocellular Carcinoma Based on Multi-Omics Analysis
por: Yin, Lu, et al.
Publicado: (2021)

Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma
por: Bai, Yang, et al.
Publicado: (2021)

Identification and Validation of a Novel Tumor Microenvironment-Related Prognostic Signature of Patients With Hepatocellular Carcinoma
por: Li, Rui, et al.
Publicado: (2022)

Identification of immunological characterization and Anoikis-related molecular clusters in rheumatoid arthritis
por: Zhao, Jianan, et al.
Publicado: (2023)

Editorial: Methods and applications in molecular diagnostics
por: Arora, Naina, et al.
Publicado: (2023)

Editorial: Weak Interactions in Molecular Machinery
por: Isaacson, Rivka L., et al.
Publicado: (2019)

Editorial: Molecular chaperones and human disease
por: Chakafana, Graham, et al.
Publicado: (2022)

Novel Molecular Subtypes Associated With 5mC Methylation and Their Role in Hepatocellular Carcinoma Immunotherapy
por: Mo, Zhuomao, et al.
Publicado: (2020)

Identifying tumor immunity-associated molecular features in liver hepatocellular carcinoma by multi-omics analysis
por: Shen, Qianyun, et al.
Publicado: (2022)

Editorial: Computational Identification of ceRNA Regulation
por: Zhang, Junpeng, et al.
Publicado: (2022)

Editorial: Structural and Functional Characterization of Circular RNAs
por: Grammatikakis, Ioannis, et al.
Publicado: (2021)

Editorial: Primary cilia as therapeutic targets
por: Nishimura, Yuhei, et al.
Publicado: (2023)

Editorial: Insights in molecular diagnostics and therapeutics: 2022
por: Becatti, Matteo, et al.
Publicado: (2023)

Editorial: The HSP70 Molecular Chaperone Machines
por: Goloubinoff, Pierre
Publicado: (2017)

Editorial: Molecular Diagnostics in the Detection of Neurodegenerative Disorders
por: Agrawal, Megha, et al.
Publicado: (2017)

Editorial: Insights in molecular diagnostics and therapeutics: 2021
por: Becatti, Matteo, et al.
Publicado: (2022)

Identification of a Five-Autophagy-Related-lncRNA Signature as a Novel Prognostic Biomarker for Hepatocellular Carcinoma
por: Deng, Xiaoyu, et al.
Publicado: (2021)

Glutamine metabolic reprogramming in hepatocellular carcinoma
por: Ye, Yanyan, et al.
Publicado: (2023)

Editorial: Heterogeneity and plasticity of prostate cancer
por: Culig, Zoran, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8286o3sv1oo1dg82e2f947vmr6